Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide
JAMA Oncology - United States
doi 10.1001/jamaoncol.2019.4636
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2020
Authors
Publisher
American Medical Association (AMA)